Biomerica (BMRA) Capital Expenditures Growth (1y) (2011 - 2023)
Biomerica (BMRA) Capital Expenditures Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -6.52% |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -75.00% |
| Aug 31, 2023 | -38.24% |
| Feb 28, 2023 | -58.14% |
| Nov 30, 2022 | 83.61% |
| Aug 31, 2022 | 561.35% |
| May 31, 2022 | -15.96% |
| Feb 28, 2022 | -68.28% |
| Nov 30, 2021 | -40.53% |
| Aug 31, 2021 | -87.01% |
| May 31, 2021 | 394.49% |
| Feb 28, 2021 | 111.18% |
| Nov 30, 2020 | 429.34% |
| Aug 31, 2020 | 1,723.49% |
| May 31, 2020 | -79.13% |
| Feb 29, 2020 | 7.72% |
| Nov 30, 2019 | -72.32% |
| Aug 31, 2019 | -94.30% |
| May 31, 2019 | -49.70% |
| Feb 28, 2019 | -7.08% |
| Nov 30, 2018 | -54.48% |